Xiidra
| Xiidra | |
|---|---|
| DOSAGE | 1 gtt BID (12 hours apart) |
| GENERIC | Lifitegrast ophthalmic solution 5% |
| SIZE | 60 vial carton |
| INDICATIONS | Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). |
| MECHANISM OF ACTION | LFA-1 Antagonist |
| MICROBIOLOGY | Inhibits T-cell activation which prevents inflammation |
| CONTRAINDICATIONS & WARNINGS | None |
| PEDIATRIC USE | Safety and effectiveness in pediatric patients have not been established in patients under 17 years old |
| PREGNANCY | Not established |
| NOTE | |